Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Health Economics & Costs

Drug to Reduce Overdose Deaths Likely Increased Drug Use and Crime

Posted on May 4, 2024 by Devon Herrick

Nearly 110,000 people died in 2023 from a drug overdose, according to the U.S. Centers for Disease Control and Prevention (CDC). That is around 300 people per day. Opioid abuse and overdose deaths are growing problems in the United States. In recent years fentanyl has flooded the illicit drug market. Virtually all prescription opioids bought off the street are counterfeit with fentanyl as the active ingredient. Many illicit drugs, like cocaine and heroin, are also laced with fentanyl to boost the strength.

+

Saturday Links

Posted on May 4, 2024May 4, 2024 by John C. Goodman
  • The opioid abuse epidemic happened under the watchful eyes of two government agencies expressly designed to prevent such problems: the FDA and the DEA.
  • Walmart’s original vision. (After watching the video, I think I know why they weren’t successful.)
  • Why is Biden delaying the ban on menthol cigarettes? My answer: He needs Black votes.
  • Yglesias: The left stands for equality vs. hierarchy.
  • Kling: au contraire — the leftist approach to government creates inequality that far exceeds the inequality produced by the market.
  • Biden is expanding Obamcare coverage to Deferred Action for Childhood Arrivals (DACA) recipients.
+

Friday Links

Posted on May 3, 2024May 3, 2024 by John C. Goodman
  • FTC to target patent abuses. (WSJ)
  • Eylea (which costs more than $1,800 for a single dose) has been granted over 90 granted patents—including one for minor adjustments to its sterile packaging.
  • Tomas Philipson: So called “patent abuses” are exaggerated.
  • What the FDA gets wrong about drugs for rare diseases.
  • Capretta: Americans spend more on healthcare than other countries because of “premium medicine”: procedures that offer minimal benefits at high cost.
  • An argument for more regulation of direct-to-consumer advertising of prescription drugs. Although very one-sided. Our biggest problem is that the chronically ill are under-consuming drugs, not over-consuming them.
+

Health Care Disruption Takes Another Hit

Posted on May 2, 2024 by Devon Herrick

Walmart has made the unfortunate decision to shutter its health clinics, the big box retailer announced. The decision was apparently sudden. Only about a month ago Walmart announced plans to add 19 more stores in 2024. In all Walmart will close all 51 of its physician-staffed clinics. Walmart is also closing its telemedicine portals as well.

+
  • Previous
  • 1
  • …
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • …
  • 405
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 39 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom